Halyard Health, Inc. (NYSE:HYH) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
operations for the three and twelve months ended December 31,
2016 in a press release dated February 27, 2017 that is attached
and incorporated herein by reference as Exhibit 99.1.
of this Current Report, is being furnished and shall not be
deemed filed for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that Section. The information in Item 2.02 of this
Current Report shall not be incorporated by reference into any
registration statement or other document to the Securities Act of
1933, as amended, except as otherwise expressly stated in such
filing.
|
(d)
|
Exhibits.
|
February 27, 2017.
About Halyard Health, Inc. (NYSE:HYH)
Halyard Health, Inc. seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. The Medical Devices segment provides a portfolio of product offerings focused on pain management and respiratory and digestive health. The S&IP segment’s product portfolio includes sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves. The S&IP segment is also a provider of education to prevent healthcare-associated infections. The Medical Devices segment provides a portfolio of product offerings focused on pain management and respiratory and digestive health. Its products include QUICK CHECK, SMART-FOLD, POWERGUARD, MICROCOOL and FLUIDSHIELD. Halyard Health, Inc. (NYSE:HYH) Recent Trading Information
Halyard Health, Inc. (NYSE:HYH) closed its last trading session down -0.09 at 41.44 with 651,573 shares trading hands.